BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rajeshkumar NV, Kers JA, Moncrief S, Defusco AW, Park JH, Handfield M. Preclinical evaluation of the maximum tolerated dose and toxicokinetics of enteric-coated lantibiotic OG253 capsules. Toxicol Appl Pharmacol 2019;374:32-40. [PMID: 31034929 DOI: 10.1016/j.taap.2019.04.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Rowe SM, Spring DR. The role of chemical synthesis in developing RiPP antibiotics. Chem Soc Rev 2021;50:4245-58. [DOI: 10.1039/d0cs01386b] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
2 Pokhrel R, Bhattarai N, Baral P, Gerstman BS, Park JH, Handfield M, Chapagain PP. Lipid II Binding and Transmembrane Properties of Various Antimicrobial Lanthipeptides. J Chem Theory Comput 2021. [PMID: 34874159 DOI: 10.1021/acs.jctc.1c00666] [Reference Citation Analysis]
3 van Staden ADP, van Zyl WF, Trindade M, Dicks LMT, Smith C. Therapeutic Application of Lantibiotics and Other Lanthipeptides: Old and New Findings. Appl Environ Microbiol 2021;87:e0018621. [PMID: 33962984 DOI: 10.1128/AEM.00186-21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]